Amprologix Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Latest Deal Amount
  • $6.71M

  • Investors
  • 6

Amprologix General Information

Description

Developer of antimicrobial-resistant drugs designed to combat drug-resistant infections. The company utilizes cutting-edge machine learning algorithms to improve antibiotic properties, including nasal decolonization of methicillin-resistant Staphylococcus aureus, pneumonia, and surface skin infections, enabling clients to combat the growing problem of antibiotic resistance.

Contact Information

Formerly Known As
AGHOCO 1738
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Derriford Research Facility
  • Plymouth Science Park, Research Way
  • Plymouth PL6 8BU
  • England, United Kingdom
+44 01752
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Derriford Research Facility
  • Plymouth Science Park, Research Way
  • Plymouth PL6 8BU
  • England, United Kingdom
+44 01752

Amprologix Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amprologix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) $6.71M In Progress Generating Revenue
6. Later Stage VC 20-Oct-2025 Completed Generating Revenue
5. Accelerator/Incubator 01-Oct-2025 Completed Generating Revenue
4. Accelerator/Incubator 02-Jun-2025 Completed Generating Revenue
3. Grant 01-Apr-2021 Completed Generating Revenue
2. Corporate 20-Sep-2018 Completed Generating Revenue
1. University Spin-Out 01-Jan-2018 Completed Startup
To view Amprologix’s complete valuation and funding history, request access »

Amprologix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 2,772,000 $0.000013 $0.06 $0.06 1x $0.06 1.83%
To view Amprologix’s complete cap table history, request access »

Amprologix Patents

Amprologix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10273272-B2 Antimicrobial peptides Active 04-Mar-2014
EP-3114134-A1 Novel antimicrobial peptides Active 04-Mar-2014
EP-3114134-B1 Novel antimicrobial peptides Active 04-Mar-2014
US-20170204146-A1 Novel antimicrobial peptides Active 04-Mar-2014
US-20120308638-A1 Antimicrobial peptides Active 17-Dec-2009 C07K7/08
To view Amprologix’s complete patent history, request access »

Amprologix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amprologix Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Plutus Investment Group Family Office Minority
Saudi Biotechnology Accelerator Accelerator/Incubator
MassChallenge Accelerator/Incubator
UK Research and Innovation Government
Ingenza VC-Backed Company Minority
You’re viewing 5 of 6 investors. Get the full list »

Amprologix FAQs

  • When was Amprologix founded?

    Amprologix was founded in 2018.

  • Where is Amprologix headquartered?

    Amprologix is headquartered in Plymouth, United Kingdom.

  • What is the size of Amprologix?

    Amprologix has 5 total employees.

  • What industry is Amprologix in?

    Amprologix’s primary industry is Drug Discovery.

  • Is Amprologix a private or public company?

    Amprologix is a Private company.

  • What is Amprologix’s current revenue?

    The current revenue for Amprologix is .

  • How much funding has Amprologix raised over time?

    Amprologix has raised $1.03M.

  • Who are Amprologix’s investors?

    Plutus Investment Group, Saudi Biotechnology Accelerator, MassChallenge, UK Research and Innovation, and Ingenza are 5 of 6 investors who have invested in Amprologix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process